MoneyWorks4Me

Mankind Pharma - Quaterly Results

27 Oct 2026 Evaluate
A fair growth of 19.27% in the revenue at Rs. 31452.20 millions was reported in the September 2026 quarter as compared to Rs. 26369.50 millions during year-ago period.Net Profit recorded in the quarter ended September 2026 rise to 26.57% to Rs. 5819.50  millions  compared to R. 4598.00 millions in corresponding previous quarter.Operating profit surged to 9915.20 millions from the corresponding previous quarter of 7815.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 31452.20 26369.50 19.27 61092.70 52066.80 17.34 104211.80 95074.10 9.61
Other Income 588.30 776.70 -24.26 927.90 1428.80 -35.06 3261.00 4934.20 -33.91
PBIDT 9915.20 7815.70 26.86 19540.60 15317.10 27.57 34120.20 29182.40 16.92
Interest 877.40 1492.20 -41.20 1826.90 2985.60 -38.81 5622.10 3769.80 49.14
PBDT 9037.80 6323.50 42.92 17713.70 12331.50 43.65 27435.70 25412.60 7.96
Depreciation 1201.90 1068.20 12.52 2312.10 2114.50 9.34 4285.70 3947.60 8.56
PBT 7835.90 5255.30 49.10 15401.60 10217.00 50.74 23150.00 21465.00 7.85
TAX 2016.40 657.30 206.77 3997.20 1466.30 172.60 2774.40 4217.40 -34.22
Deferred Tax 529.00 -318.10 -266.30 856.40 -430.50 -298.93 -1957.80 -481.90 306.27
PAT 5819.50 4598.00 26.57 11404.40 8750.70 30.33 20375.60 17247.60 18.14
Equity 413.00 412.80 0.05 413.00 412.80 0.05 412.80 412.60 0.05
PBIDTM(%) 31.52 29.64 6.36 31.99 29.42 8.73 32.74 30.69 6.67
Peers
Company Name CMP
Sun Pharma. Inds. 1762.15
Dr. Reddys Labs. 1315.25
Cipla 1363.20
Lupin 1958.70
Zydus Lifesciences 1176.00
View more..